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Homeostatic synaptic scaling is a negative feedback response to
fluctuations in synaptic strength induced by developmental or
learning-related processes, which maintains neuronal activity stable.
Although several components of the synaptic scaling apparatus have
been characterized, the intrinsic regulatory mechanisms promoting
scaling remain largely unknown. MicroRNAs may contribute to
posttranscriptional control of mRNAs implicated in different stages
of synaptic scaling, but their role in these mechanisms is still under-
valued. Here, we report that chronic blockade of glutamate receptors
of the AMPA and NMDA types in hippocampal neurons in culture
induces changes in the neuronal mRNA and miRNA transcriptomes,
leading to synaptic upscaling. Specifically, we show that synaptic
activity blockade persistently down-regulates miR-186-5p. Moreover,
we describe a conserved miR-186-5p-binding site within the 3′UTR of
the mRNA encoding the AMPA receptor GluA2 subunit, and demon-
strate that GluA2 is a direct target of miR-186-5p. Overexpression of
miR-186 decreased GluA2 surface levels, increased synaptic expres-
sion of GluA2-lacking AMPA receptors, and blocked synaptic scaling,
whereas inhibition of miR-186-5p increased GluA2 surface levels and
the amplitude and frequency of AMPA receptor-mediated currents,
and mimicked excitatory synaptic scaling induced by synaptic inactiv-
ity. Our findings elucidate an activity-dependent miRNA-mediated
mechanism for regulation of AMPA receptor expression.
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The dynamic nature of neuronal circuits, constantly changingsynapse number and strength during development and
learning-related processes, induces powerful destabilization in
neuronal networks. These destabilizing forces are counter-
balanced by a set of compensatory mechanisms that maintain
network stability, known as homeostatic plasticity (1–3). Synaptic
scaling, a form of homeostatic plasticity, acts through a negative
feedback mechanism, scaling synaptic strength globally by
adjusting synaptic AMPA receptor (AMPAR) content (2, 4, 5).
Notably, dysfunction of proteins associated with the synaptic
scaling machinery has been reported in several neurological
disorders, suggesting that defective homeostatic plasticity sig-
naling can contribute to disease pathogenesis (6, 7).
Although many components of the synaptic scaling apparatus
have been identified, most associated with synapse stabilization
and AMPAR trafficking during development and synaptic plas-
ticity (7–10), full understanding of how transcriptional and
translational programs are regulated by these paradigms is still
lacking. The time frame of synaptic scaling suggests that tran-
scriptional and posttranscriptional responses may be activated
upon chronic changes in neuronal activity, but these alterations
are still poorly characterized. Chronic blockade of action po-
tentials with tetrodotoxin (TTX) affects transcription through
reduction of CaMKIV activation (11), T voltage-gated calcium
channel-dependent Ca2+ signaling, and activity-regulated tran-
scription factors like SRF and ELK1 (12). Proteomic analysis of
newly synthesized proteins in day in vitro (DIV) 21 hippocampal
neurons subjected to upscaling or downscaling paradigms allowed
the identification of bidirectionally regulated proteins, many of
which are known regulators of synaptic function (13). Furthermore,
adjustments in the postsynaptic density proteome occur during
sleep, a process associated with homeostatic downscaling (14).
However, little is known about homeostatic plasticity-associated
posttranscriptional regulatory mechanisms that control how modi-
fications in the neuronal transcriptome are echoed in the proteome.
MicroRNAs (miRNAs) are small noncoding RNAs that play
critical roles in posttranscriptional regulation of gene expression.
In neurons, miRNA expression changes rapidly in response to
neuronal activity, controlling the translation of multiple tran-
scripts (15–17). Consequently, miRNAs regulate numerous neuronal
processes, ranging from differentiation to synaptic plasticity (18–21).
However, few miRNAs have been functionally implicated in synaptic
upscaling mechanisms: miR-92a levels are decreased in neurons in-
cubated with TTX and the NMDA receptor antagonist APV,
allowing the expression of its direct target GluA1 (22), whereas
miR-124, increased in neurons treated with TTX and APV, tran-
siently represses GluA2 expression in early stages of synaptic
upscaling (23). Therefore, it is likely that the contribution of
miRNA-regulated mechanisms to synaptic upscaling is still
largely underestimated.
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ates synaptic scaling triggered by prolonged blockade of
synaptic activity.
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Here, we demonstrate that chronic blockade of glutamate
receptors of the AMPA and NMDA (NMDARs) types in hip-
pocampal neurons induces upscaling of AMPAR-mediated
miniature excitatory postsynaptic currents (mEPSCs), increases
the GluA1 and GluA2 synaptic content, and alters the neuronal
transcriptome and miRNA profile. MicroRNA-186-5p (miR-
186-5p) was found to be rapidly and persistently down-regulated
by synaptic activity suppression, to be a regulator of endogenous
GluA2 expression, and of AMPAR-mediated currents. Fur-
thermore, inhibition of basal miR-186-5p expression occluded
synaptic upscaling triggered by chronic synaptic inactivity, re-
vealing that miR-186-5p has a functional role in synaptic scaling
mechanisms.
Results
Chronic Blockade of AMPARs and NMDARs Promotes Synaptic
Upscaling in Hippocampal Neurons. Synaptic upscaling has been
modeled using several protocols that result in increased synaptic
strength by chronically blocking neuronal and synaptic activity
(24–27). Homeostatic regulation of synaptic function can be in-
duced by chronic blockade of action potentials (with TTX), or by
prolonged antagonism of AMPARs or NMDARs, or a combi-
nation of both (see ref. 28 for a review of different inactivity
paradigms used to study homeostatic synaptic adaptations). The
responses to decreased action potential firing and silencing of
glutamatergic receptors have different underlying mechanisms
and probably contribute to different physiological goals, which
remain largely unexplored. In this study, we induced synaptic
scaling in mature hippocampal neurons with long-term blockade
of synaptic activity, through inhibition of AMPA and synaptic
NMDA receptors with the noncompetitive antagonists GYKI-
52466 (29, 30) and MK-801 (31), respectively. Whole-cell
AMPAR-mediated mEPSCs were recorded in hippocampal
neurons treated with 50 μMGYKI-52466 and 10 μMMK-801 for
24 h or in control conditions (Fig. 1A). Chronic blockade of
AMPARs and NMDARs increased mEPSC frequency and am-
plitude (Fig. 1 B and C), in agreement with other reports (26, 32,
33). To investigate whether this increase in mEPSC amplitude is
multiplicative, a defining feature of synaptic scaling, we ranked
control amplitudes of mEPSCs against amplitudes in neurons
treated with GYKI-52466 and MK-801 and the data were well fit
by a linear function with a slope of 2.22. The cumulative distri-
bution of the mEPSC amplitude data from GYKI-52466– and
MK-801–treated hippocampal neurons scaled by the multipli-
cative factor was almost perfectly superimposable over the dis-
tribution of data from control neurons (Fig. 1D), indicating a
multiplicative effect. These results show that chronic blockade of
AMPARs and NMDARs promotes synaptic upscaling of
AMPAR-mediated mEPSC amplitude.
To assess the effects of chronic blockade of AMPARs and
NMDARs on surface expression and composition of AMPARs,
hippocampal neurons treated with GYKI-52466 and MK-801 for
24 h, or in control conditions, were labeled for surface GluA1 or
GluA2, and for the dendritic marker MAP2 and the synaptic
marker VGluT1 (Fig. 1 E and G). The intensity, area, and
number of VGluT1 clusters were not changed upon synaptic
activity blockade (SI Appendix, Fig. S1A), suggesting that the
change in the frequency of mEPSCs (Fig. 1 A and B) is not due
to a change in synapse number. However, the synaptic surface
GluA1 clusters (colocalized with VGluT1 clusters) presented
more than twofold increase in their intensity, area, and number
upon synaptic activity suppression (Fig. 1F). Moreover, scaled
distribution of synaptic GluA1 intensities, in GYKI-52466– and
MK-801–treated hippocampal neurons, was nearly super-
imposed with distribution of intensities from control hippocam-
pal neurons (SI Appendix, Fig. S1B), in agreement with a
multiplicative increase on the intensity of synaptic GluA1-
containing AMPAR clusters. Similarly, synaptic surface
GluA2 clusters (labeled with an anti-GluA2 specific antibody)
(SI Appendix, Fig. S2) were increased with synaptic activity
suppression for 24 h (Fig. 1H), also in a multiplicative manner
(SI Appendix, Fig. S1C). Total cell surface levels of both
GluA1 and GluA2 were also increased in hippocampal neurons
treated for 24 h with GYKI-52466 and MK-801 (SI Appendix,
Fig. S1 D and E). Given previous work suggesting differential
roles for calcium-permeable vs. GluA2-containing AMPARs in
different synaptic scaling paradigms (25–27, 34–39), we tested
the sensitivity of mEPSCs to the calcium-permeable AMPAR
inhibitor Naspm, in control conditions and in neurons submitted
to synaptic activity blockade for 24 h (SI Appendix, Fig. S3 A and
B). We found that synaptic upscaling of AMPAR currents oc-
curred in the presence of Naspm (SI Appendix, Fig. S3C), and
that the percentage of inhibition of mEPSCs by Naspm was not
significantly changed upon chronic synaptic activity blockade (SI
Appendix, Fig. S3D).
In summary, chronic suppression of synaptic activity in
hippocampal neurons, through blockade of AMPARs and
NMDARs, induces upscaling of synaptic strength, likely by a
concurrent regulation of both GluA1 and GluA2 subunits.
Synaptic Scaling Regulates the Neuronal Transcriptome and miRNA
Profile in Hippocampal Neurons. Synaptic scaling has been exten-
sively studied to identify and comprehend the molecular players
and signaling pathways behind compensatory homeostatic
mechanisms that modulate synaptic strength in response to
prolonged changes in neuronal activity (7). In particular, chronic
blockade of neuronal and synaptic activity has been shown to
promote synaptic scaling through transcription- or translation-
dependent mechanisms (11, 12, 35, 36). However, the exact
mechanisms and how they impact on the synaptic scaling appa-
ratus are still largely unknown.
To investigate the effects of synaptic upscaling in the neuronal
transcriptome, whole-genome rat gene expression microarray
analysis was performed using total RNA from hippocampal
neurons in control conditions or treated with GYKI-52466 and
MK-801 for 9 or 26 h (Fig. 2A and SI Appendix, Tables S1 and
S2) (40). Venn diagram analysis, performed using the jvenn web
tool (41), showed that 30 transcripts were up-regulated and
60 transcripts were down-regulated in both experimental condi-
tions. In addition, 46 transcripts were shown to be up-regulated
with 9 h of chronic synaptic activity blockade, but their levels
were significantly decreased upon 26 h of treatment, whereas
19 transcripts followed the opposite pattern of expression (Fig.
2B). These observations are in agreement with a recent study
reporting different sets of newly synthesized proteins in early and
late stages of homeostatic responses (42). Subsequently, it was
our aim to identify biological processes and signaling pathways
involved in synaptic scaling. Sets of up-regulated and down-
regulated genes upon chronic blockade of synaptic activity
were analyzed with the Gene Ontology Consortium web tool.
This analysis aimed to pinpoint gene ontology classes related
with neuronal/brain processes and with enriched representation
in the altered gene sets, in which a gene can be associated with
more than one category. Overall, enrichment of transcripts as-
sociated with synaptic signaling, transmission and plasticity, be-
havior and cognition was detected (Fig. 2C), consistent with
many reports linking proteins involved in synaptic plasticity
mechanisms with synaptic scaling (7–10). Datasets for down-
regulated transcripts upon 9 h of treatment showed enrichment
for transcripts associated with G protein-coupled receptor-
signaling pathway (Fig. 2C).
Among the transcripts regulated by activity suppression, we
found several molecules previously associated with synaptic
scaling mechanisms, such as Arc, Bdnf, CamKIIβ, Grin1, Plk2,
Rps6ka5, and Rara (SI Appendix, Tables S1 and S2) (24, 36,
43–48). Additionally, the levels of Lrrtm2, Mdga1, Nlgn1,
Nlgn3, Npas4, and Syn1, associated with synaptogenesis and
stability of excitatory and inhibitory synapses (49–59), were
also found altered (SI Appendix, Tables S1 and S2), suggesting
that homeostatic mechanisms regulating excitatory/inhibitory
synaptic balance may also take place with this paradigm of
activity blockade (60).
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To identify miRNAs regulating synaptic upscaling mecha-
nisms, we built a screening panel of selected miRNAs, based on
gene-expression alterations upon 9 h of chronic blockade of
activity using GYKI-52466 and MK-801. Briefly, altered tran-
scripts associated with a set of gene ontology categories relevant
for synaptic function were chosen to predict possible miRNA
regulators, by using three independent prediction algorithms:
miRanda, miRTarget2, and TargetScan6.1 (Fig. 3A). We then
built a screening panel comprised of selected miRNAs predicted
to target a large number of altered transcripts, by at least two
different algorithms, and according to synaptic relevance of the
putative targets, number of putative targets, and miRNA:mRNA
target score (Fig. 3A and SI Appendix, Table S3).
MicroRNA profiling was performed for 16 miRNAs in hip-
pocampal neurons in control conditions or treated for 2, 4, 9, or
24 h with GYKI-52466 and MK-801. We identified several
activity-regulated miRNAs, with miR-186-5p, miR-190a-5p,
miR-193a-3p, and miR-544-3p exhibiting the most dramatic
changes in their expression levels (Fig. 3B). These results reveal
that prolonged AMPAR and NMDAR blockade regulates the
miRNA profile in neurons, possibly by different parallel mech-
anisms, because bidirectional alterations in miRNA levels were
detected and some miRNAs were more rapidly regulated than
others (Fig. 3B). Curiously, with the present activity suppression
paradigm, we did not find significant changes in the expression
levels of miR-92a-3p or miR-124-3p (SI Appendix, Fig. S4) pre-
viously found to be regulated by neuronal activity blockade
manipulation (22, 23). To select possible miRNA regulators
involved in the synaptic scaling mechanism, three key aspects
were taken into consideration: (i) miRNA expression levels in
neurons, (ii) how fast the miRNA responded to synaptic ac-
tivity suppression, and (iii) putative targets with synaptic rel-
evance (besides those identified in the microarray analysis).
According to these criteria, miR-186-5p was selected for
further scrutiny due to its presence in fair levels in neurons
and its rapid and persistent regulation upon synaptic activity
blockade (Fig. 3C).
Because a single miRNA has the potential to regulate hun-
dreds of transcripts, we predicted putative targets for miR-186-
5p using the TargetScan7.1 algorithm (61) and performed gene
ontology enrichment analysis using the Gene Ontology Consor-
tium web tool to assess the possible impact of miR-186-5p in
neuronal function. Interestingly, PANTHER pathway analysis
showed enrichment in transcripts associated with the ionotropic
glutamate receptor pathway, hinting for a function in synaptic
plasticity (Fig. 3D and SI Appendix, Fig. S5A). High-throughput
strategies have recently been used to understand miRNA tar-
geting and to identify their targets. Moore, et al. (62) performed
precipitation and identification of AGO:miRNA-bound RNAs
from mouse brain. We used these data to investigate miR-186-5p
targets in the mouse brain and found enrichment in transcripts
involved in neuronal development, synapse assembly, and syn-
aptic plasticity (SI Appendix, Fig. S5B). Importantly, this analysis
also unraveled enrichment in targets related with activation of
Fig. 1. Chronic activity blockade of AMPARs and
NMDARs upscales AMPARs in hippocampal neurons.
(A) Representative whole-cell current traces of
AMPAR-mediated mEPSCs from hippocampal neu-
rons in control conditions or treated with 50 μM
GYKI-52466 and 10 μM MK-801 for 24 h. (Scale bars:
vertical, 20 pA; horizontal, 5 s.) Mean frequency (B)
and amplitude (C) of AMPAR-mediated mEPSCs
upon chronic synaptic activity blockade (n = 11–
13 neurons per condition, three independent prep-
arations; Mann–Whitney test: *P ≤ 0.05, ***P ≤
0.001). (D) Cumulative probability histograms of
mEPSC amplitude. The cumulative probability curve
of “synaptic activity blockade” amplitude was
scaled by dividing by a factor of 2.22 (n = 1,650–
1,950 events recorded from 11 to 13 cells per con-
dition, three independent preparations). (E and G)
Representative images of hippocampal neurons in
control conditions or treated with GYKI-52466 and
MK-801 for 24 h and stained for surface GluA1 (E )
or surface GluA2 (G), VGluT1 and MAP2. Arrows
indicate colocalization of surface staining (yellow)
and VGluT1 puncta (cyan); arrowheads pinpoint
VGluT1 puncta (cyan) that do not colocalize with
GluA clusters. (Scale bars, 5 μm.) (F and H) Intensity,
area and number of synaptic GluA1 (F ) or GluA2 (G)
clusters (colocalizing with VGluT1 clusters) per den-
dritic length (n = 29–33 neurons, three independent
experiments; Mann–Whitney test: **P ≤ 0.01, ***P ≤
0.001, ****P ≤ 0.0001).
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AMPA receptors, trafficking of GluA2-containing AMPA re-
ceptors, and activation of the NMDA receptor upon glutamate
binding and postsynaptic events (SI Appendix, Fig. S5B). To-
gether, these results support the hypothesis that miR-186-5p is
an important regulator of synaptic processes and synaptic
plasticity mechanisms.
miR-186-5p Regulates Endogenous GluA2 Expression. One of miR-
186-5p’s possible targets is the GluA2-coding transcript Gria2,
which has a highly conserved putative binding site for miR-186-
5p in its 3′UTR (Fig. 4A). Moreover, upon chronic blockade of
synaptic activity miR-186-5p levels were inversely correlated with
GluA2 levels (Figs. 1H and 3C), hinting that miR-186-5p may
regulate GluA2. To test this hypothesis we assessed whether
synaptic activity deprivation results in translational enhancement
dependent on posttranscriptional regulatory mechanisms asso-
ciated with Gria2 3′ UTR. We used a reporter construct con-
taining the full-length Gria2 3′UTR downstream of the gaussia
luciferase coding sequence; secreted alkaline phosphatase
(SEAP) expressed from the same vector was used for normali-
zation. Transfected hippocampal neurons were treated for 24 h
with GYKI-52466 and MK-801 before luciferase activity was
evaluated. Indeed, chronic blockade of synaptic activity in-
creased luciferase activity regulated by the Gria2 3′UTR (Fig.
4B), whereas activity blockade did not significantly affect lucif-
erase expression in neurons expressing the control vector.
To test whether miR-186-5p directly regulates GluA2 ex-
pression, we cotransfected HEK293T cells or cortical neuron
cultures with the luciferase reporter fused to Gria2 3′UTR and
Fig. 3. Chronic blockade of synaptic activity regulates miRNA levels. (A)
Workflow leading to the selection of a miRNA panel. Transcripts differently
expressed upon 9 h of synaptic activity blockade, from eight different gene
ontology categories, were used to predict putative miRNA regulators (mi-
Randa, miRTarget2, TargetScan 6.1). Sixteen miRNAs were chosen for
screening. (B) Heatmap representation of the neuronal miRNA profile in
hippocampal cultures in control conditions or upon incubation with GYKI-
52466 and MK-801. Data were normalized to global mean and each data
point refers relative change. (C) Relative levels of miR-186-5p were down-
regulated upon synaptic activity blockade (n = 3–4; one sample t test: *P ≤
0.05, ***P ≤ 0.001). (D) Prediction of conserved putative targets of miR-186-
5p revealed an enrichment of targets associated with pathways of synaptic
relevance. Gene ontology analysis was performed for PANTHER pathways
using the Gene Ontology Consortium database (binomial statistical test with
Bonferroni correction for multiple testing: P ≤ 0.05).
Fig. 2. Chronic synaptic activity blockade alters the transcriptome of hip-
pocampal neurons. (A) Heat-map representation of transcripts significantly
changed in whole-genome rat gene-expression microarrays, in hippocampal
cultured neurons subjected to synaptic activity blockade with GYKI-52466 and
MK-801 for 9 h or 26 h. Transcripts with a fold-change ≥ 2.0 cut-off were con-
sidered; each data point refers to averaged fold change for triplicates (n = 3 in-
dependent experiments; t test: P ≤ 0.05). (B) Venn diagram representing the
overlap of up- and down-regulated gene sets upon activity blockade for 9 or
26 h. (C) Gene ontology analysis exposes enrichment of differently expressed
transcripts associated with synaptic transmission and plasticity. Only categories
with statistical significance were considered and nonredundant neuroscience
related categories were selected for graphical representation (binomial statistical
test with Bonferroni correction for multiple testing: P ≤ 0.05).
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either premiR-186, to overexpress miR-186-5p, or miR-186-5p
inhibitors, or the respective control vectors expressing scram-
bled sequences. In both cell systems, expression of premiR-
186 significantly decreased luciferase signal and, conversely,
miR-186-5p inhibition increased luciferase expression (Fig. 4 C
and D). Therefore, these results suggest that GluA2 is a direct
target of miR-186-5p. To determine if direct interaction of miR-
186-5p:Gria2 occurs in the predicted target site, we generated a
mutant reporter construct containing point mutations in the
putative binding site of Gria2 3′UTR (Fig. 4E). Whereas coex-
pression of premiR-186 and wild-type Gria2 3′UTR decreased
luciferase signal, coexpression with the Gria2 3′UTR mutant
abolished this effect in cortical neurons (Fig. 4F), demonstrating
miR-186-5p:Gria2 3′UTR interaction at this site.
Consequently, we characterized the regulatory role of miR-
186-5p on endogenous GluA2 expression in hippocampal neu-
rons by expressing the precursor form of miR-186 or inhibiting
miR-186-5p. Expression of premiR-186 decreased the intensity,
area, and number of total (SI Appendix, Fig. S6A) and synaptic
(Fig. 5 A and B) cell surface GluA2 clusters in hippocampal
neurons, and the number of VGluT1+ synapses colocalizing with
cell surface GluA2 (Fig. 5C). We then investigated whether
AMPAR composition was altered in neurons expressing premiR-
186 taking advantage of Naspm. Expression of premiR-186 did
not significantly affect the amplitude or frequency of AMPAR-
mediated mEPSCs (SI Appendix, Fig. S7), but Naspm produced a
higher inhibitory effect in the amplitude of mEPSCs in neurons
expressing premiR-186 compared with neurons expressing a
scrambled control (Fig. 5D–F), indicating that miR-186 expression
increases the synaptic content of GluA2-lacking AMPARs.
Conversely, neurons expressing miR-186-5p inhibitors presented
an increase in the intensity, area, and number of total (SI Ap-
pendix, Fig. S6B) and synaptic cell surface GluA2 clusters (Fig. 6
A and B), and exhibited more VGluT1+ synapses colocalizing
with cell surface GluA2 (Fig. 6C). Inhibiting endogenous miR-
186-5p was sufficient to scale up mEPSC frequency and ampli-
tude (Fig. 6 D–G), indicating that endogenous miR-186-5p levels
contribute to decrease excitatory transmission. These results
show that miR-186-5p regulates the synaptic content of endog-
enous GluA2-containing AMPARs, and impacts AMPAR-
mediated synaptic transmission in hippocampal neurons.
miR-186-5p Affects Synaptic Upscaling in Hippocampal Neurons.
Considering the previous results, we examined whether over-
expression or inhibition of miR-186-5p basal expression affects
synaptic upscaling triggered by synaptic activity blockade. We
expressed a scramble sequence or the precursor form of miR-
186 in hippocampal neurons, which were later subjected to
synaptic activity suppression for 24 h, before mEPSCs were
evaluated (Fig. 7A). Chronic blockade of synaptic activity in-
duced upscaling of mEPSC frequency and amplitude in neu-
rons expressing a scramble sequence (Fig. 7 A–D). However,
premiR186 expression blocked the increase in the frequency
Fig. 4. Gria2 3′UTR is a direct target of miR-186-5p.
(A) miR-186-5p:Gria2 3′UTR site interaction is highly
conserved in mammals. Putative site prediction
performed with TargetScan and RNA hybridization
analyzed with RNAhybrid. (B) Hippocampal neurons
expressing guassia luciferase under the control of Gria2
3′UTR showed increased expression of guassia luciferase
upon chronic blockade of synaptic activity with GYKI-
52466 and MK-801 for 24 h (n = 3; one sample t test:
*P ≤ 0.05). (C and D) HEK293T cells (C) or cortical neu-
rons (D) expressing luciferase reporter constructs
(pGluc-Gria2-3′UTR or pGLuc-Control) and premiR-
186 or miR-186-5p inhibitors constructs (or respective
scramble sequences) presented an inverse correlation
between expression of miR-186-5p and luciferase un-
der the control of Gria2 3′UTR (n = 8 or 3 for premiR-
186 expression experiments and n = 6 for miR-186-5p
inhibition; one sample t test: *P ≤ 0.05, **P ≤ 0.01). (E)
The predicted miR-186-5p seed region targeted site
in the Gria2 3′UTR was partially mutated. (F) Cortical
neurons expressing luciferase constructs (control pGLuc-
Control, pGLuc-GluA2-3′UTR containing the wild-type
Gria2 3′UTR or pGLuc-GluA2-3′UTR containing mu-
tated Gria2 3′UTR) and premiR-186 or scramble
expressing constructs confirmed this site as a miR-186-
5p target site (n = 3; one-sample t test: *P ≤ 0.05; n.s.,
not significant). (B–D and F) Luciferase expression was
normalized for SEAP activity (expressed from the same
vector) and with luciferase coexpressed with scramble
controls.
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(Fig. 7B) and amplitude (Fig. 7 C and E) of mEPSCs induced by
synaptic activity suppression.
On the other hand, we tested whether inhibition of miR-186-
5p expression affected synaptic scaling. Transfected hippocampal
neurons expressing miR-186-5p inhibitors, or a scrambled se-
quence, were subjected to chronic synaptic activity blockade with
GYKI-52466 and MK-801 for 24 h or maintained in control
conditions. As shown previously (Figs. 1H and 6 A and B), both
chronic blockade of synaptic activity and basal inhibition of miR-
186-5p increased synaptic cell surface GluA2 levels (Fig. 7 F and
G). However, chronic blockade of synaptic activity failed to
further up-regulate GluA2 synaptic levels in neurons expressing
miR-186-5p inhibitors (Fig. 7G), suggesting that miR-186-5p
inhibition up-regulates GluA2 cell surface levels through mech-
anisms shared with those activated by synaptic activity suppres-
sion. Subsequently, the functional role of miR-186-5p in synaptic
scaling was evaluated by analyzing AMPAR-mediated mEPSCs.
Inhibition of miR-186-5p, which elevated mEPSC amplitude and
frequency in basal conditions (Fig. 6 D–G), blocked further
scaling-up induced by chronic blockade of AMPARs and
NMDARs (Fig. 7 H–J). The combined cumulative probability
distribution analysis also evidenced these differences, with syn-
aptic activity blockade inducing a shift toward increased ampli-
tude of AMPAR-mediated mEPSCs in neurons expressing a
scrambled sequence (Fig. 7K), but not in neurons expressing
miR-186-5p inhibitors (Fig. 7L). In summary, the elevation in
mEPSC amplitude and frequency induced by miR-186-5p in-
hibition occluded further homeostatic adjustment triggered by
synaptic activity suppression. Overall, these results support a role
for miR-186-5p in synaptic scaling triggered by chronic synaptic
activity blockade.
Discussion
Synaptic scaling is an important homeostatic mechanism re-
sponsible for maintaining neuronal network activity within a
physiological and dynamic range throughout developmental,
experience, and environmental changes (2, 63). The mechanisms
promoting synaptic scaling can be influenced by neuronal model,
developmental age, and activity paradigms (28, 64, 65), revealing
the existence of distinct processes underlying scaling (11, 35, 66).
Here, we report that chronic blockade of AMPARs and
NMDARs for 24 h promotes synaptic scaling of AMPAR-
mediated mEPSC amplitude, in accordance with previous stud-
ies using this activity-deprivation paradigm in different neuronal
models (26, 32, 33) and also reports on neurons subjected to
chronic blockade of AMPARs only (24, 27, 66–68). Scaling of
AMPAR-mediated currents induced by chronic blockade of
AMPARs and NMDARs was accompanied by scaling of synaptic
GluA1 and GluA2 content, in agreement with previous obser-
vations in spinal cord neurons (26, 69). However, chronic
blockade of AMPARs alone enhances postsynaptic contribution
of GluA1 homomers in cortical and hippocampal neurons (27,
Fig. 5. Expression of premiR-186 regulates the expression of endogenous GluA2. (A) Representative images of hippocampal neurons expressing premiR-
186 or control scramble constructs and stained for surface GluA2, VGluT1, and MAP2. Transfected neurons were identified by expression of EGFP from the
premiR-186 expression plasmid. Arrows indicate colocalization of surface GluA2 (yellow) and VGluT1 puncta (cyan); arrowheads pinpoint GluA2-lacking
VGluT1 puncta (cyan). (Scale bars, 5 μm.) (B) Intensity, area and number of endogenous synaptic surface GluA2 clusters (colocalizing with VGluT1 clusters)
normalized to synapse density (n = 29–32 cells per condition from three independent experiments; Mann–Whitney test: **P ≤ 0.01). (C) Neurons expressing
premiR-186 displayed a decreased density of VGluT1+ synapses containing surface GluA2 clusters (n = 29–32 cells per condition, three independent experi-
ments; Mann–Whitney test: *P ≤ 0.05). (D) Representative whole-cell current traces of AMPAR-mediated mEPSCs from hippocampal neurons expressing a
scramble control or premiR-186, under control conditions or preincubated with 20 μMNaspm for 30 min. (Scale bars: vertical, 10 pA; horizontal, 5 s.) (E) Naspm
decreased the amplitude of AMPAR-mediated mEPSCs of neurons expressing premiR-186 (n = 7–10 cells per condition, five independent experiments; two-
way ANOVA with Tukey’s multiple comparison test: **P ≤ 0.01). (F) PremiR-186 expressing neurons displayed a higher percentage of inhibition with Naspm
than control neurons (n = 7–9 cells per condition, five independent experiments; Mann–Whitney test: *P ≤ 0.05).
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67), hinting that different mechanisms are responsible for syn-
aptic scaling upon chronic blockade of AMPARs alone or of
AMPARs and NMDARs.
The functional relevance of several proteins in synaptic scaling
has been investigated, although the underlying mechanisms re-
main largely unknown, as few high-throughput studies have ex-
amined how the neuronal transcriptome is modified at different
stages of the scaling process (12, 70). In this work, we analyzed
the neuronal transcriptome of hippocampal neurons upon
chronic blockade of synaptic activity for 9 and 26 h. Gene on-
tology enrichment analysis showed altered transcripts associated
with synaptic signaling and synaptic plasticity classes. In addition
to transcripts previously associated with synaptic scaling—such
as Arc, Bdnf, CamKIIβ, Plk2, Rps6ka5, and Rara (24, 36, 43, 44,
47, 48)—we now identify several transcripts associated with
synaptogenesis—including Lrrtm2, Mdga1, Nlgn1, Nlgn3, Npas4,
and Syn1 (49–59)—suggesting that this paradigm of chronic ac-
tivity blockade may also elicit adjustments in excitatory/inhibitory
synaptic balance (60).
Some paradigms of neuronal activity blockade require de novo
protein translation (25, 34, 35, 66), indicating a relevant function
for posttranscriptional regulatory mechanisms in this process.
The involvement of miRNAs has been reported both in synaptic
scaling-down and scaling-up mechanisms: downscaling para-
digms regulate miR-485, miR-134, and miR-129-5p levels, which
in turn target, respectively, SV2A, Pum2, and ATP2B4 and
DCX, important players in downscaling mechanisms (71–73).
On the other hand, miR-92a and miR-124 are implicated in
upscaling paradigms by targeting GluA1 and GluA2 (22, 23).
Here, we performed miRNA profiling of a small set of miRNAs,
which are predicted regulators of altered transcripts identified in
hippocampal neurons submitted to 9 h of synaptic activity
blockade. We observed that synaptic activity deprivation regu-
lates the levels of several miRNAs at different stages of scaling,
in agreement with previous studies (17, 22, 23). In addition, our
results reveal a dramatic and persistent decrease in miR-186-5p
levels after 2 h of treatment with GYKI-52466 and MK-801 and
up to 24 h of incubation, suggesting a functional role for this
miRNA from early stages of synaptic upscaling induced by syn-
aptic activity blockade.
miR-186-5p is a highly conserved miRNA in mammals,
expressed in the spinal cord and across multiple brain subre-
gions, with enriched expression in neurons (74). Furthermore,
expression of this miRNA can be regulated as a physiological
response to stress in intestinal, prefrontal cortex, and hippo-
campal tissues (75, 76), and by extrinsic factors, such as meth-
amphetamine or alcohol intake (77, 78). A group of brain-
enriched transcripts present a conserved putative binding site
for the miR-186-5p seed region (79), and gene ontology analysis
of miR-186-5p putative and AGO:miR-186-5p–bound targets
(62) revealed an enrichment of neuronal targets associated with
neuronal and synaptic development and synaptic plasticity, in-
cluding several targets related with the ionotropic glutamate
receptor pathway. Among this pool of putative and AGO:miR-
186-5p–bound targets is Gria2, encoding GluA2. We report
that miR-186-5p targets GluA2 and regulates endogenous
GluA2 expression under physiological conditions through a di-
rect target site in Gria2 3′UTR. Furthermore, miR-186-5p in-
hibition elevates the synaptic content of GluA2, and the
frequency and amplitude of AMPA receptor-mediated currents,
Fig. 6. Inhibition of miR-186-5p scales up excitatory synaptic strength. (A) Representative images of hippocampal neurons expressing miR-186-5p inhibitors
or control scramble constructs and stained for surface GluA2, VGluT1, and MAP2. Transfected neurons were identified by expression of mCherry from the
bicistronic miR-186-5p inhibitors expression plasmid. Arrows indicate colocalization of surface GluA2 (yellow) and VGluT1 puncta (cyan); arrowheads pinpoint
GluA2-lacking VGluT1 puncta (cyan). (Scale bars, 5 μm.) (B) Intensity, area, and number of endogenous synaptic GluA2 clusters (colocalizing with
VGluT1 clusters) normalized to synapse density (n = 49 cells from five independent experiments; Mann–Whitney test: **P ≤ 0.01, ***P ≤ 0.001). (C) Inhibition
of miR-186-5p elevated the density of VGluT1+ synapses containing surface GluA2 (n = 49 cells from five independent experiments; Mann–Whitney test:
***P ≤ 0.001). (D) Representative whole-cell current traces of AMPAR-mediated mEPSCs from hippocampal neurons expressing a scramble sequence or miR-
186–5p inhibitors. (Scale bars: vertical, 10 pA; horizontal, 5 s.) Expression of miR-186-5p inhibitors increased AMPAR-mediated mEPSC frequency (E) and
amplitude (F) (n = 18 cells per condition, 10 independent experiments; Mann–Whitney test: *P ≤ 0.05). (G) Cumulative probability histograms of mEPSC
amplitudes display the increase induced by miR-186-5p inhibition (n = 2,400 events recorded from 16 cells per condition, 10 independent experiments).
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Fig. 7. Manipulation of basal miR-186-5p levels blocks synaptic scaling-up. (A) Representative whole-cell current traces of AMPAR-mediated mEPSCs from
hippocampal neurons expressing a scramble control or premiR-186, and treated with 50 μM GYKI-52466 and MK-801 for 24 h. (Scale bars: vertical, 10 pA;
horizontal, 5 s.) (B and C) Expression of premiR-186 hinders the increase of AMPAR-mediated mEPSC frequency (B) and amplitude (C) induced by chronic
blockade of synaptic activity (n = 12–14 neurons per condition, six independent preparations). (D and E) Cumulative probability histograms of mEPSC am-
plitudes display the synaptic scaling associated with chronic blockade of excitatory synaptic activity in neurons expressing scramble control (D), but not in
premiR-186–expressing neurons (E) (n = 1,800 events recorded from 16 cells per condition, six independent experiments). (F) Representative images of
hippocampal neurons expressing either miR-186-5p inhibitors or control scramble constructs, in control conditions or treated with GYKI-52466 and MK-801 for
24 h, and stained for surface GluA2, VGluT1, and MAP2. Transfected neurons were identified by expression of mCherry from the bicistronic miR-186-5p
inhibitors expression plasmid. Arrows indicate colocalization of surface GluA2 (yellow) and VGluT1 puncta (cyan); arrowheads pinpoint GluA2-lacking
VGluT1 puncta (cyan). (Scale bars, 5 μm.) (G) Inhibition of basal miR-186-5p expression occluded upscaling of synaptic GluA2 clusters intensity upon block-
ade of synaptic activity. Synaptic GluA2 clusters (colocalized with VGluT1) were normalized to synapse density (n = 29–30 neurons per condition, three in-
dependent experiments). (H) Representative whole-cell current traces of AMPAR-mediated mEPSCs from hippocampal neurons expressing a scrambled
sequence or miR-186-5p inhibitors, and exposed to GYKI-52466 and MK-801 for 24 h. (Scale bars: vertical, 10 pA; horizontal, 5 s.) (I and J) Inhibiting the basal
levels of miR-186-5p hampered the increase of AMPAR-mediated mEPSC frequency (I) and amplitude (J) induced by blockade of synaptic activity (n = 16–
18 neurons per condition, 10 independent preparations). (K and L) Cumulative probability histograms of mEPSC amplitudes display synaptic scaling associated
with chronic synaptic activity suppression in neurons expressing scrambled inhibitors (K), but not in miR-186-5p inhibitor-expressing neurons (L) (n =
2,400 events, 16 cells per condition, 10 independent experiments). (B, C, G, I, and J) Statistical analysis was performed using two-way ANOVA with Tukey’s
multiple comparison test: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.
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while miR-186 overexpression decreases the synaptic content of
GluA2-containing AMPAR, as shown by the increased sensitivity
to Naspm, an inhibitor of GluA2-lacking AMPAR. This evidence
indicates that miR-186-5p regulates synaptic transmission and
the subunit composition of AMPARs. Few miRNAs have been
identified as direct regulators of AMPAR expression in a neu-
ronal activity-dependent manner: miR-92a, miR-137, and miR-
501-3p were found to regulate GluA1 (22, 80, 81), and miR-
124 and miR-181a regulate GluA2 expression (23, 82, 83). We
now report miR-186-5p as a regulator of GluA2 expression and
AMPAR subunit composition. Interestingly, analysis of Ago:
miR-186-5p–precipitated targets (62) shows an enrichment of
transcripts associated with the trafficking of GluA2-containing
AMPARs—including NSF (84, 85) and PRKCB (86–88)—sug-
gesting that besides regulating GluA2 levels, miR-186-5p may
regulate additional mechanisms participating in the GluA2-
containing AMPAR trafficking apparatus.
Because miR-186-5p levels are decreased by synaptic activity
blockade, and miR-186-5p targets GluA2, the levels of which are
up-regulated upon prolonged synaptic activity suppression, we
evaluated the role of miR-186-5p on synaptic upscaling. PremiR-
186 overexpression blocked synaptic scaling, presumably by
down-regulating GluA2 levels. Conversely, miR-186-5p in-
hibition is sufficient to increase cell surface levels of GluA2 at
synapses, and to induce upscaling of AMPAR-mediated mEPSC
amplitude. We also report that prolonged synaptic activ-
ity blockade fails to further increase cell surface synaptic
GluA2 levels and upscaling of mEPSCs in neurons expressing
miR-186-5p inhibitors. These results indicate that high levels of
miR-186-5p interfere with synaptic scaling, and that miR-186-5p
inhibition occludes the synaptic scaling-associated mechanisms
that lead to up-regulation of GluA2 levels and increased
AMPAR-mediated currents. It is possible that basal miR-186-5p
inhibition also negatively interferes with synaptic upscaling
mechanisms, since GluA2 synaptic levels detected upon basal
miR-186-5p inhibition plus activity blockade do not reach
GluA2 levels found upon activity suppression in control neurons.
In fact, miR-124 was found to transiently down-regulate GluA2-
containing AMPAR upon chronic blockade of action potentials
and NMDAR, even though this effect was abolished at later time
points, when GluA2-containing receptors were found upscaled
(23). However, we did not observe significant changes in the
expression of miR-124-3p upon suppression of synaptic activity
(SI Appendix, Fig. S4A). Taken together, our results strongly
implicate miR-186-5p in synaptic scaling mechanisms associated
with suppression of synaptic activity in hippocampal neurons.
Overall, our work demonstrates that chronic blockade of
synaptic activity in hippocampal neurons induces upscaling of
AMPAR-mediated mEPSC amplitude with an increase in
GluA1 and GluA2 synaptic content. The mechanisms underlying
synaptic scaling affect the neuronal mRNA transcriptome and
miRNA profile, although the signaling pathways triggering these
effects remain unclear. Furthermore, suppression of excitatory
synaptic activity decreases the levels of miR-186-5p, a nega-
tive regulator of GluA2 expression. Expression of the miR-
186 precursor abolishes synaptic scaling upon synaptic activity
suppression, whereas inhibition of miR-186-5p basal levels en-
hances excitatory transmission and occludes the increase in cell
surface GluA2 content and synaptic scaling-up of AMPAR me-
diated mEPSCs triggered by synaptic activity blockade. Together,
these results indicate an important regulatory function for miR-
186-5p in regulating GluA2 and synaptic upscaling mechanisms.
Materials and Methods
mEPSC Recording and Analysis. Whole-cell voltage-clamp recordings were
made at room temperature from 15 DIV hippocampal neurons plated on
coverslips. The recording chamber was perfused with extracellular solution
supplemented with 100 μM picrotoxin, 500 ηM TTX, and 50 μM APV. For
3 min, AMPAR-mediated mEPSC events were recorded in a gap-free acqui-
sition mode with a sampling rate of 25 kHz after signal filtering at 2.8 kHz.
Only events larger than 2× the recording noise and decay τ between 2 and
30 ms were considered. For analysis of AMPARs composition, hippocampal
neurons were preincubated with 20 μM of the selective Ca2+-permeable
AMPAR antagonist Naspm for 30 min–60 min, and then recorded in the
presence of the drug.
Imaging and Quantification. Fluorescence imaging for puncta analysis was
performed using a widefield Zeiss Axio Observer Z1 inverted microscope (Carl
Zeiss) equipped with an AxioCam HRm camera and with ZEN blue software
(Carl Zeiss). Images were acquired with a 63× Plan-ApoChromat oil objective
(numerical aperture 1.4). For each independent experiment, neurons were
cultured and stained simultaneously. Dendrites with similar thickness and
appearance were randomly selected using MAP2 staining and exposure time
was defined to avoid pixel saturation. All experimental conditions within
independent preparations were imaged using identical settings.
Images were quantified using image analysis software FIJI (89), taking
advantage of a semiautomatic macro designed for this purpose. The area of
interest was randomly selected by using MAP2 staining for nontransfected
cells and GFP or mCherry staining for transfected cells. Dendritic length was
measured in the area of interest, using one of the mentioned channels. To
quantify the proteins of interest, images were subjected to a user-defined
intensity threshold, to have defined protein clusters, and user-defined
background intensity was subtracted in all images. Each protein cluster
present in the area of interest was analyzed and measurements of intensity,
area, and number were obtained. Synaptic clusters were selected by over-
lapping clusters of interest with thresholded VGluT1 clusters. All results are
normalized to dendritic length or synapse density, as indicated in image
captions. This analysis was performed blind to the experimental condition.
Statistical Analysis. Graphs and statistical analyses were performed using
GraphPad Prism 6 software. Outliers were identified using raw experimental
data with the ROUT or Grubbs method. Data are presented as mean ± SEM of
generally three or more experiments, performed in independent prepara-
tions, as indicated in the figure captions. Statistical differences were ana-
lyzed as indicated in the figure captions.
Additional details are available in SI Appendix, SI Materials and Methods.
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